237 related articles for article (PubMed ID: 18237197)
1. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
[TBL] [Abstract][Full Text] [Related]
2. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Vandooren J; Van den Steen PE; Opdenakker G
Crit Rev Biochem Mol Biol; 2013; 48(3):222-72. PubMed ID: 23547785
[TBL] [Abstract][Full Text] [Related]
3. Insights into the structure and domain flexibility of full-length pro-matrix metalloproteinase-9/gelatinase B.
Rosenblum G; Van den Steen PE; Cohen SR; Grossmann JG; Frenkel J; Sertchook R; Slack N; Strange RW; Opdenakker G; Sagi I
Structure; 2007 Oct; 15(10):1227-36. PubMed ID: 17937912
[TBL] [Abstract][Full Text] [Related]
4. Gelatinase B functions as regulator and effector in leukocyte biology.
Opdenakker G; Van den Steen PE; Dubois B; Nelissen I; Van Coillie E; Masure S; Proost P; Van Damme J
J Leukoc Biol; 2001 Jun; 69(6):851-9. PubMed ID: 11404367
[TBL] [Abstract][Full Text] [Related]
5. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing.
Schönbeck U; Mach F; Libby P
J Immunol; 1998 Oct; 161(7):3340-6. PubMed ID: 9759850
[TBL] [Abstract][Full Text] [Related]
6. Construction, expression, and characterization of a baculovirally expressed catalytic domain of human matrix metalloproteinase-9.
Sadatmansoori S; MacDougall J; Khademi S; Cooke LS; Guarino L; Meyer EF; Forough R
Protein Expr Purif; 2001 Dec; 23(3):447-52. PubMed ID: 11722182
[TBL] [Abstract][Full Text] [Related]
7. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells.
Illman SA; Lehti K; Keski-Oja J; Lohi J
J Cell Sci; 2006 Sep; 119(Pt 18):3856-65. PubMed ID: 16940349
[TBL] [Abstract][Full Text] [Related]
8. Protease analysis by neoepitope approach reveals the activation of MMP-9 is achieved proteolytically in a test tissue cartilage model involved in bone formation.
Lee ER; Lamplugh L; Kluczyk B; Mort JS; Leblond CP
J Histochem Cytochem; 2006 Sep; 54(9):965-80. PubMed ID: 16709729
[TBL] [Abstract][Full Text] [Related]
9. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
Jani M; Tordai H; Trexler M; Bányai L; Patthy L
Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
[TBL] [Abstract][Full Text] [Related]
10. Pro-MMP-9 activation by the MT1-MMP/MMP-2 axis and MMP-3: role of TIMP-2 and plasma membranes.
Toth M; Chvyrkova I; Bernardo MM; Hernandez-Barrantes S; Fridman R
Biochem Biophys Res Commun; 2003 Aug; 308(2):386-95. PubMed ID: 12901881
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1.
Olson MW; Bernardo MM; Pietila M; Gervasi DC; Toth M; Kotra LP; Massova I; Mobashery S; Fridman R
J Biol Chem; 2000 Jan; 275(4):2661-8. PubMed ID: 10644727
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro.
Warner RL; Bhagavathula N; Nerusu KC; Lateef H; Younkin E; Johnson KJ; Varani J
Exp Mol Pathol; 2004 Jun; 76(3):189-95. PubMed ID: 15126100
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous propeptide processing of mini-stromelysin-1 mutants blocked by APMA ((4-Aminophenyl)mercuric acetate).
Galazka G; Windsor LJ; Birkedal-Hansen H; Engler JA
Biochemistry; 1999 Jan; 38(4):1316-22. PubMed ID: 9930993
[TBL] [Abstract][Full Text] [Related]
14. Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins.
Piccard H; Van den Steen PE; Opdenakker G
J Leukoc Biol; 2007 Apr; 81(4):870-92. PubMed ID: 17185359
[TBL] [Abstract][Full Text] [Related]
15. German cockroach frass proteases cleave pro-matrix metalloproteinase-9.
Hughes VS; Page K
Exp Lung Res; 2007; 33(3-4):135-50. PubMed ID: 17558676
[TBL] [Abstract][Full Text] [Related]
16. The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors.
Van den Steen PE; Van Aelst I; Hvidberg V; Piccard H; Fiten P; Jacobsen C; Moestrup SK; Fry S; Royle L; Wormald MR; Wallis R; Rudd PM; Dwek RA; Opdenakker G
J Biol Chem; 2006 Jul; 281(27):18626-37. PubMed ID: 16672230
[TBL] [Abstract][Full Text] [Related]
17. Identification of nitroglycerin-induced cysteine modifications of pro-matrix metalloproteinase-9.
Krishnatry AS; Kamei T; Wang H; Qu J; Fung HL
Rapid Commun Mass Spectrom; 2011 Aug; 25(16):2291-8. PubMed ID: 21766372
[TBL] [Abstract][Full Text] [Related]
18. Meprins process matrix metalloproteinase-9 (MMP-9)/gelatinase B and enhance the activation kinetics by MMP-3.
Geurts N; Becker-Pauly C; Martens E; Proost P; Van den Steen PE; Stöcker W; Opdenakker G
FEBS Lett; 2012 Dec; 586(24):4264-9. PubMed ID: 23123160
[TBL] [Abstract][Full Text] [Related]
19. Role of the hemopexin domain of matrix metalloproteinases in cell migration.
Dufour A; Sampson NS; Zucker S; Cao J
J Cell Physiol; 2008 Dec; 217(3):643-51. PubMed ID: 18636552
[TBL] [Abstract][Full Text] [Related]
20. Natural haemozoin modulates matrix metalloproteinases and induces morphological changes in human microvascular endothelium.
Prato M; D'Alessandro S; Van den Steen PE; Opdenakker G; Arese P; Taramelli D; Basilico N
Cell Microbiol; 2011 Aug; 13(8):1275-85. PubMed ID: 21707906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
